CytomX Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $120.5M
Liabilities Breakdown FY2024
Total Liabilities: $121.0M
Asset Breakdown
Total Assets: $120.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $38.1M | 31.6% |
| Accounts Receivable | $3.1M | 2.6% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.5M | 2.0% |
| Goodwill | $949.0K | 0.8% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $76.0M | 63.0% |
Liabilities Breakdown
Total Liabilities: $121.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 0.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $119.9M | 99.1% |